1-6 of 6
Victoria Shi
Close
Sort by
Journal Articles

T Cells Expressing a Novel Fully-Human Anti-CD19 Chimeric Antigen Receptor Induce Remissions of Advanced Lymphoma in a First-in-Humans Clinical Trial

Jennifer N. Brudno, MD, Victoria Shi, David Stroncek, MD, Stefania Pittaluga, MD PhD, Jennifer A. Kanakry, MD, Lauren M. Curtis, MD, Juan C. Gea-Banacloche, MD, Steven Pavletic, MD, Mohammad-Hadi Bagheri, MD, Jeremy J. Rose, MS, Rashmika Patel, Brenna Hansen, Ronald E. Gress, MD, James N. Kochenderfer, MD
Journal: Blood
Blood (2016) 128 (22): 999.
https://doi.org/10.1182/blood.V128.22.999.999
Published: 2016
Journal Articles

T cells expressing an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

Clinical Trials & Observations
Syed Abbas Ali, Victoria Shi, Irina Maric, Michael Wang, David F. Stroncek, Jeremy J. Rose, Jennifer N. Brudno, Maryalice Stetler-Stevenson, Steven A. Feldman, Brenna G. Hansen, Vicki S. Fellowes, Frances T. Hakim, Ronald E. Gress, James N. Kochenderfer
Journal: Blood
Blood (2016) 128 (13): 1688–1700.
https://doi.org/10.1182/blood-2016-04-711903
Published: 2016
Includes: Supplemental data
Journal Articles

Remissions of Multiple Myeloma during a First-in-Humans Clinical Trial of T Cells Expressing an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor

Syed Abbas Ali, MD, Victoria Shi, Michael Wang, MD, David Stroncek, MD, Irina Maric, Jennifer N Brudno, MD, Maryalice Stetler-Stevenson, Jeremy J. Rose, BA, Steven Feldman, Brenna Hansen, Frances T. Hakim, PhD, Ronald E. Gress, MD, James N. Kochenderfer, MD
Journal: Blood
Blood (2015) 126 (23): LBA-1.
https://doi.org/10.1182/blood.V126.23.LBA-1.LBA-1
Published: 2015
Journal Articles

Allogeneic T-Cells Expressing an Anti-CD19 Chimeric Antigen Receptor Cause Remissions of B-Cell Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation without Causing Graft-Versus-Host Disease

Jennifer N Brudno, MD, Robert Somerville, Victoria Shi, Jeremy J. Rose, BA, David C. Halverson, MD, Daniel H. Fowler, MD, Dennis D. Hickstein, MD, Juan C. Gea-Banacloche, MD, Steven Z. Pavletic, Andre Goy, MD, Tangying L Lu, Steven Feldman, Alex Iwamoto, Roger Kurlander, Irina Maric, Brenna Hansen, Jennifer S. Wilder, RN, Bazetta Blacklock-Shuver, Frances T. Hakim, Steven A. Rosenberg, MD PhD, Ronald E. Gress, MD, James N. Kochenderfer, MD
Journal: Blood
Blood (2015) 126 (23): 99.
https://doi.org/10.1182/blood.V126.23.99.99
Published: 2015
Journal Articles

Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action

Zhengxing Qu, David M. Goldenberg, Thomas M. Cardillo, Victoria Shi, Hans J. Hansen, Chien-Hsing Chang
Journal: Blood
Blood (2008) 111 (4): 2211–2219.
https://doi.org/10.1182/blood-2007-08-110072
Published: 2008
Includes: Supplemental data
Journal Articles

Recombinant Bispecific Monoclonal Antibody (bsMAb) Against CD20 and CD22 Active In Vitro and In Vivo Against B-Cell Lymphomas.

Zhengxing Qu, PhD, Thomas M. Cardillo, PhD, Victoria Shi, MSc, Diana L. Delaney, MSc, Hans J. Hansen, PhD, Chien-Hsing Chang, PhD, David M. Goldenberg, ScD,MD
Journal: Blood
Blood (2006) 108 (11): 2521.
https://doi.org/10.1182/blood.V108.11.2521.2521
Published: 2006